SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

Cardinal Health agrees to pay $26.8 million settlement over monopoly charges The proposed federal court order aims to restore competition in six markets

CMS star rating system finds physician-owned hospitals most satisfactory Of the participating physician-owned hospitals, 67 percent received four stars or more

So long, 'doc fix': Obama signs SGR repeal into law After almost 20 years, 'doc fix' legislation finally put out of its misery

Twitter may help predict ED visits for chronic conditions Asthma incurs over $50 million in annual medical costs

BIOTRONIK gets FDA nod for a first of its kind implantable cardioverter defibrillator Inventra DX is capable of ultra-high energy, 42 joules, initial shock

Health Care: The soft underbelly of cyber security how to protect your medical identity from cyberthreats

Brain imaging shows link between Down syndrome, Alzheimer’s: study PET imaging and MRI scans showed changes in the brains of people with Down syndrome, who are at higher risk for developing Alzheimer's disease, according to a new study

Dealing with staff addicts in the workplace New York radiologist allegedly wrote 280 illegal prescriptions

MWA 2015: Assessing the risk of pandemics and the promise of 3-D printing The show kicks off in ten days. What can visitors expect?

Illinois Health and Science to acquire IBA Molecular North America, Inc. IBAM NA will work with Zevacor to produce radionuclides

IBA spin-off, Novation ink PET radiopharmaceutical deal

by Brendon Nafziger , DOTmed News Associate Editor
Ion Beam Applications S.A.'s newly spun-off radiopharmaceutical wing IBA Molecular has inked a five-year deal with group purchasing organization Novation LLC to supply its member health care facilities with PET radiotracers.

Under the deal, announced Monday, IBA Molecular will supply imaging agents, including 18-Fluorodeoxyglucose, as well as provide educational and training services. The contract took effect July 1. Terms of the deal weren't disclosed.

Story Continues Below Advertisement

qualiTEE - reliabiliTEE - repairabiliTEE - we guaranTEE

Bayer HealthCare Multi Vendor Service will repair your probe with the same precision and care you provide to your patients. Call us at 1-844-MVS-5100 (1-844-687-5100) or visit www.ri.bayer.com



IBA Molecular has 54 PET isotope facilities in Europe, North America and Asia. It also delivers agents for SPECT imaging worldwide.

SK Capital Partners holds a controlling stake in IBA Molecular, which was spun off from its Belgian parent company, which retains a minority stake, in April.

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2015 DOTmed.com, Inc.
ALL RIGHTS RESERVED